MicroRNA pathway could lead to new avenues for leukemia treatment
Tuesday, April 26, 2016 - 14:30
in Health & Medicine
A particular signaling route in microRNA (miR-22) has been identified that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.